Aspect Clinical   Report issue

For profit Phase 3
Founded: Ledbury United Kingdom (1971)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2014
NCT02158481
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Reading Clinical Research Aspect

Active Ingredients

Drugs in Phase 3 Trials (2)

amlodipine (norvasc) (1 trial)

celecoxib (celebrex) (1 trial)

Drugs in Other Trials (2)

carotenoids (1 trial)

l-epigallocatechin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertension (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4